Jan 11, 2022 / 08:45PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing AbbVie today at the 40th Annual JPMorgan Healthcare Conference.
From the company, we're going to have a presentation from Rob Michael, the CFO; and we'll have Mike Severino, President of AbbVie; and Jeff Stewart, Chief Commercial Officer, joining us for the Q&A.
So Rob, Mike, Jeff, Happy New Year. Thanks for joining us, and I look forward to the presentation.
Robert A. Michael - AbbVie Inc. - Vice Chairman of Finance & Commercial Operations and CFO
Great. So thank you, Chris, and good afternoon, everyone. It's a pleasure to be here today. Before I begin, please take a moment to review our forward-looking statements on Slide 2.
Turning to Slide 3. Since AbbVie's inception, we have developed and assembled a broad portfolio of diversified growth assets with leadership positions across several attractive markets, including immunology, hematologic
Abbvie Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers